Page 17, line 19 - “89% of the patients had concomitant medication before randomization”. What
medication? Other medication for treating COVID-19 or medication for treating chronic comorbidities??
Data about what medicines the patients belonging to each group are taking are not shown in table 1. For
example, it is not clear how many patients in each group were taking antiviral drugs? These are
confounding variables and it is not clear how the authors treat these data… they present general results
and also results from post-hoc subgroup analysis. However, information about this post-hoc subgroup
analysis is not clear.
Why the number of follow-up days is one day more for SOC group?
The first sentence of the page is about authorship and not information for methods section.